Healthcare - Biotechnology - NASDAQ - US
$ 26.49
-3.67 %
$ 2.48 B
Market Cap
-11.93
P/E
INCOME STATEMENT
0
REVENUE
-171 M
OPERATING INCOME
-166 M
NET INCOME
EFFICIENCY
Earnings Waterfall
Scholar Rock Holding Corporation
| Revenue | 0 |
| Cost Of Revenue | 2.84 M |
| Gross Profit | -2.84 M |
| Operating Expenses | 171 M |
| Operating Income | -171 M |
| Other Expenses | -5.51 M |
| Net Income | -166 M |
Income Statement
Millions
| Dec-2023 | Dec-2022 | Dec-2021 | Dec-2020 | Dec-2019 | Dec-2018 | Dec-2017 | Dec-2016 | |
|---|---|---|---|---|---|---|---|---|
| REVENUE | ||||||||
| Revenue | 0 | 33.2 | 18.8 | 15.4 | 20.5 | 0 | 0 | 0.4 |
| GROSS PROFIT | ||||||||
| Cost Of Revenue | 2.8 | 9.9 | 9.0 | 74.1 | 54.2 | 0.8 | 0.7 | 12.5 |
| Gross Profit | (2.8) | 23.3 | 9.8 | (58.7) | (33.7) | (0.8) | (0.7) | (12.1) |
| OPERATING INCOME | ||||||||
| Operating Expenses | 171.3 | 167.6 | 148.7 | 102.3 | 75.0 | 50.7 | 25.0 | 16.6 |
| Selling, General and Administrative Expenses | 49.4 | 43.1 | 40.3 | 28.2 | 20.8 | 14.4 | 5.1 | 4.1 |
| Research and Development Expenses | 119.1 | 124.4 | 108.5 | 74.1 | 54.2 | 36.3 | 19.9 | 12.5 |
| Operating Income | (171.3) | (134.4) | (129.9) | (86.9) | (54.5) | (50.7) | (25.0) | (16.2) |
| PRE-TAX INCOME | ||||||||
| Interest Income Expense | 0 | (2.9) | 0 | 0 | 0 | 0 | 0 | 0 |
| Total Other Income | 5.5 | (0.1) | (1.9) | 0.4 | 3.5 | 1.4 | 34 K | 3 K |
| Pre-Tax Income | (165.8) | (134.5) | (131.8) | (86.5) | (51.0) | (49.3) | (25.0) | (16.2) |
| NET INCOME | ||||||||
| Tax Provision | 0 | (2.9) | 2.4 | (1.5) | (1.3) | 1.4 | 44 K | 19 K |
| Net Income | (165.8) | (131.6) | (131.8) | (85.0) | (49.7) | (49.3) | (25.0) | (16.2) |
| EPS | 1.99 | 2.21 | 3.59 | 2.77 | 1.8 | 3.15 | 1.4 | 0.91 |